$ELAB
PMGC Holdings Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ELAB up today? It is at $6.62 (+8.52%), and our scanner flagged it 6 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ELAB spikes, and full due diligence on ELAB — key stats, earnings, dilution and insider activity. Free.
Get free $ELAB alerts the moment volume spikes
Our scanner flagged $ELAB 6 times in the last 30 days. Create a free account to track $ELAB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $6.62
- Change today
- +8.52%
- Previous close
- $6.10
- 52-week range
- $0.540 – $267.12
- Market cap
- $30M
- Institutional own.
- 3.29%
- Total held
- 3.3%
- Tradeable float
- 4.4M 97% of shares · after <1% insiders + 3% institutions
- Short interest
- 440K ▼ -46% vs prior · as of 2026-07-31
- Short % of float
- 10.0%
- Days to cover
- 1.0d
- Avg daily volume
- 2.6M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5mthin
- 0.4x
- 15mthin
- 0.1x
- 1hthin
- 0.2x
- 1D
- --
Get free ELAB + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ELAB up today?
Here is the latest on ELAB from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $ELAB runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 26,247 new shares (adjusted for the later reverse split)
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$ELAB Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ELAB Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to ELAB
Comparable names in pharmaceutical preparations, closest in size first.
ELAB stock FAQ
Why is $ELAB up today?
Here is the latest on ELAB from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
What is the ELAB stock price today?
ELAB last traded at $6.62, up 8.52% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live ELAB alerts?
The ELAB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ELAB 6 times in the last 30 days.
What exchange is ELAB on?
ELAB (PMGC Holdings Inc. Common Stock) trades on XNAS, with a market cap of about $30M in the PHARMACEUTICAL PREPARATIONS sector.
Is ELAB good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ELAB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.